Cargando…
Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360926/ https://www.ncbi.nlm.nih.gov/pubmed/37477520 http://dx.doi.org/10.18632/oncotarget.28479 |
_version_ | 1785076120967708672 |
---|---|
author | Zhou, Jianli Sturtevant, Drew Love, Cassie Kulkarni, Aditya Biyani, Neha Kathad, Umesh Thacker, Elizabeth Dave, Sandeep Bhatia, Kishor |
author_facet | Zhou, Jianli Sturtevant, Drew Love, Cassie Kulkarni, Aditya Biyani, Neha Kathad, Umesh Thacker, Elizabeth Dave, Sandeep Bhatia, Kishor |
author_sort | Zhou, Jianli |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10360926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-103609262023-07-22 Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair Zhou, Jianli Sturtevant, Drew Love, Cassie Kulkarni, Aditya Biyani, Neha Kathad, Umesh Thacker, Elizabeth Dave, Sandeep Bhatia, Kishor Oncotarget Addendum Impact Journals LLC 2023-07-20 /pmc/articles/PMC10360926/ /pubmed/37477520 http://dx.doi.org/10.18632/oncotarget.28479 Text en Copyright: © 2023 Zhou et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Addendum Zhou, Jianli Sturtevant, Drew Love, Cassie Kulkarni, Aditya Biyani, Neha Kathad, Umesh Thacker, Elizabeth Dave, Sandeep Bhatia, Kishor Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair |
title | Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair |
title_full | Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair |
title_fullStr | Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair |
title_full_unstemmed | Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair |
title_short | Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair |
title_sort | addendum: lp-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-hodgkin’s lymphoma models and in cells deficient in dna damage repair |
topic | Addendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360926/ https://www.ncbi.nlm.nih.gov/pubmed/37477520 http://dx.doi.org/10.18632/oncotarget.28479 |
work_keys_str_mv | AT zhoujianli addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair AT sturtevantdrew addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair AT lovecassie addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair AT kulkarniaditya addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair AT biyanineha addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair AT kathadumesh addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair AT thackerelizabeth addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair AT davesandeep addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair AT bhatiakishor addendumlp284asmallmoleculeacylfulveneexertspotentantitumoractivityinpreclinicalnonhodgkinslymphomamodelsandincellsdeficientindnadamagerepair |